Dr. Przespolewski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Elm and Carlton St
Buffalo, NY 14263Phone+1 716-845-2300
Education & Training
University at BuffaloFellowship, Hematology and Medical Oncology, 2014 - 2017- University at BuffaloResidency, Internal Medicine, 2011 - 2014
Lake Erie College of Osteopathic MedicineClass of 2011
Certifications & Licensure
NY State License 2014 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old Start of enrollment: 2021 Jul 29
Publications & Presentations
PubMed
- Immune Checkpoint Inhibitor Therapy and Associations with Clonal Hematopoiesis.Abhay Singh, Nuria Mencia Trinchant, Rahul Mishra, Kirti Arora, Smit Mehta
International Journal of Molecular Sciences. 2024-10-15 - 1 citationsAcute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.Bijal Shah, Ryan J Mattison, Ramzi Abboud, Peter Abdelmessieh, Ibrahim Aldoss
Journal of the National Comprehensive Cancer Network. 2024-10-01 - 4 citationsGemtuzumab ozogamicin plus standard induction hemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia.Hassan Awada, Mina Abdelmalek, Tara Cronin, Jeffrey Baron, Zakariya Kashour
Blood Cancer Journal. 2023-09-04
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
